Journal profile · Genetics & Heredity
American Journal of Medical Genetics Part C Seminars in Medical Genetics
ISSN 1552-4868 · eISSN 1552-4876 · Wiley-Liss Inc. · UNITED STATES · Quarterly · Founded 2003
American Journal of Medical Genetics Part C Seminars in Medical Genetics: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.36; hybrid open access; APC about USD 3,460; median 124 days to acceptance (57 articles, last 24 months); community-reported acceptance: moderate; 58 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
American Journal of Medical Genetics Part C Seminars in Medical Genetics is published by Wiley-Liss Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Prenatal Screening and Diagnostics, Genomics and Rare Diseases and Genomic variations and chromosomal abnormalities, together about 23% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Seminars in Medical Genetics, Part C of the American Journal of Medical Genetics (AJMG) , serves as both an educational resource and review forum, providing critical, in-depth retrospectives for students, practitioners, and associated professionals working in fields of human and medical genetics. Each issue is guest edited by a researcher in a featured area of genetics, offering a collection of thematic reviews from specialists around the world. Seminars in Medical Genetics publishes four times per year.
From the journal's Aims & Scope
Research area (LetPub): Genetics & Heredity
Editorial board by country: none in mainland China; most named United States 30, Germany 4, Canada 4, Japan 3, Italy 3 (58 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Prenatal Screening and DiagnosticsMedicine8%
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology7.8%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology7.1%
- Connective tissue disorders researchBiochemistry, Genetics and Molecular Biology7.1%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology6.3%
- Hedgehog Signaling Pathway StudiesBiochemistry, Genetics and Molecular Biology5.4%
- Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesBiochemistry, Genetics and Molecular Biology5.2%
- Neurogenetic and Muscular Disorders ResearchMedicine5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Genetics & Heredity | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedPsycINFOCAB AbstractsCurrent ContentsPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.36LetPub ·
- Impact factor (publisher)
- 2.5Publisher website ·
- Impact factor (publisher) 2025
- 2.5Publisher website ·
- CiteScore 2026-06
- 7.8LetPub ·
- CiteScore (publisher)
- 7.8Publisher website ·
- CiteScore (publisher) 2025
- 7.8Publisher website ·
- SJR 2026-06
- 1.2LetPub ·
- SNIP 2026-06
- 1.48LetPub ·
- h-index
- 93LetPub ·
- h-index
- 124OpenAlex ·
- i10-index
- 802OpenAlex ·
- 2-year mean citedness
- 1.67OpenAlex ·
- Self-citation rate
- 4%LetPub ·
- Share of gold OA articles
- 39.58%LetPub ·
Volume
- Articles per year
- 29LetPub ·
- Articles per year (publisher) 2025
- 35Publisher website ·
- Downloads per year (publisher) 2025
- 558,904Publisher website ·
Articles by year OpenAlex count · 1,323 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 11 | 8 | 0 |
| 2025 | 58 | 38 | 114 |
| 2024 | 46 | 30 | 78 |
| 2023 | 64 | 43 | 396 |
| 2022 | 70 | 44 | 1,213 |
| 2021 | 92 | 23 | 946 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
124 daysMedian, submission to acceptance · P25–P75 88 days – 213 days
- Acceptance to online
- median 15 days (58 articles)
- Submission to online
- median 153 days
- Sample
- 57 articles with submission and acceptance dates (76 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Acceptance rate (publisher)
- 57%Publisher website ·
- Acceptance rate (publisher) 2025
- 57%Publisher website ·
- Submission to first decision
- 21 daysPublisher website ·
- Submission to first decision 2025
- 21 daysPublisher website ·
- Submission to acceptance 2025
- 108 daysPublisher website ·
- Acceptance to publication 2025
- 15 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,460 / EUR 2,890 / GBP 2,330 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 200 words
- Keywords
- ≤ 7
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Self-archiving
- Authorship AUTHOR CONTRIBUTION STATEMENT
Author contributions section required on title page for original articles Model summary
For original articles, a dedicated Author Contributions section must be included on the title page of the paper to provide information about individual author contributions to the work. It is expected that all authors will have reviewed, discussed, and agreed to their individual contributions prior to submission. The contributions of all authors must be described. The contribution statement will b…
Source ↗Publisher website ·- Conflicts of interest DISCLOSURE STATEMENT
Conflict of interest statement required during submission Model summary
The Journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise, that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Poten…
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Data availability statement required for all accepted manuscripts Model summary
All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. For details on what to include in this section, see …
Source ↗Publisher website ·- Publication ethics Publication Ethics
Member of Committee on Publication Ethics (COPE) Model summary
This journal is a member of the Committee on Publication Ethics (COPE). Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- License & copyright For authors signing the copyright transfer agreement
If the open access option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs.
Source ↗Publisher website ·- Open access For authors choosing open access
If the open access option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Source ↗Publisher website ·- Self-archiving Self-Archiving Definitions and Policies
Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Liss Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 2003
- ISSN
- 1552-4868
- Electronic ISSN
- 1552-4876
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about American Journal of Medical Genetics Part C Seminars in Medical Genetics
What CAS zone is American Journal of Medical Genetics Part C Seminars in Medical Genetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, American Journal of Medical Genetics Part C Seminars in Medical Genetics is in Zone 3 of Medicine, and in Zone 3 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of American Journal of Medical Genetics Part C Seminars in Medical Genetics?
The latest impact factor listed by LetPub is 2.36; CiteScore 7.8, h-index 124.
How long does peer review take at American Journal of Medical Genetics Part C Seminars in Medical Genetics?
Based on the dates recorded on 57 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 124 days (interquartile range 88–213 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Moderate”; the journal's website gives an acceptance rate of 57% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of American Journal of Medical Genetics Part C Seminars in Medical Genetics?
According to the journal's author guidelines: Abstract: 200 words; Keywords: ≤ 7; Reference style: Author–date; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of American Journal of Medical Genetics Part C Seminars in Medical Genetics based?
Of the 58 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (30), Germany (4) and Canada (4). Counted from the institutions listed on the board page; for reference only.
Which databases index American Journal of Medical Genetics Part C Seminars in Medical Genetics?
According to LetPub and DOAJ records, American Journal of Medical Genetics Part C Seminars in Medical Genetics is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, PsycINFO, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is American Journal of Medical Genetics Part C Seminars in Medical Genetics open access, and what is the APC?
American Journal of Medical Genetics Part C Seminars in Medical Genetics is a hybrid journal. For open-access publication: APC about USD 3,460.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .